Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study

Clinical trial NCT07287137 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07287137
Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

COVID -19 COVID - 19 COVID 19 Influenza Respiratory Virus Respiratory Viruses Respiratory Virus Infection Respiratory Virus Infections

Start date: 2025-11-12
Primary completion: 2027-09-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.